Abstract:BACKGROUND: Traumatic spinal cord injuries (SCI) have devastating consequences for the physical, financial, and psychosocial well-being of patients and their caregivers. Expediently delivering interventions during the early postinjury period can have a tremendous impact on long-term functional recovery.PATHOPHYSIOLOGY: This is largely due to the unique pathophysiology of SCI where the initial traumatic insult (primary injury) is followed by a progressive secondary injury cascade characterized by ischemia, proapoptotic signaling, and peripheral inflammatory cell infiltration. Over the subsequent hours, release of proinflammatory cytokines and cytotoxic debris (DNA, ATP, reactive oxygen species) cyclically adds to the harsh postinjury microenvironment. As the lesions mature into the chronic phase, regeneration is severely impeded by the development of an astroglial-fibrous scar surrounding coalesced cystic cavities. Addressing these challenges forms the basis of current and upcoming treatments for SCI.MANAGEMENT: This paper discusses the evidence-based management of a patient with SCI while emphasizing the importance of early definitive care. Key neuroprotective therapies are summarized including surgical decompression, methylprednisolone, and blood pressure augmentation. We then review exciting neuroprotective interventions on the cusp of translation such as Riluzole, Minocycline, magnesium, therapeutic hypothermia, and CSF drainage. We also explore the most promising neuroregenerative strategies in trial today including Cethrin™, anti-NOGO antibody, cell-based approaches, and bioengineered biomaterials. Each section provides a working knowledge of the key preclinical and patient trials relevant to clinicians while highlighting the pathophysiologic rationale for the therapies.CONCLUSION: We conclude with our perspectives on the future of treatment and research in this rapidly evolving field.

Pharmacological Treatment of Acute Spinal Cord Injuries In The Light Of Recent Developments

Comprehensive Therapeutics Targeting the Corticospinal Tract Following Spinal Cord Injury

Update on the treatment of spinal cord injury

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Therapeutic Effect of Curcumin and Methylprednisolone in the Rat Spinal Cord Injury.

Pharmacologic Therapy for Spinal Cord Injury

Traumatic Spinal Cord Injury—Repair and Regeneration

Resveratrol Treatment of Spinal Cord Injury in Rat Model.

Advances and Challenges in Spinal Cord Injury Treatments

Epidemiology, Demographics, and Pathophysiology of Acute Spinal Cord Injury

The experimental study of combined methylprednisolone and nimodipine in treatment of early spinal cord injury in rats

Modern Medical Management of Spinal Cord Injury

Time is spine: a review of translational advances in spinal cord injury

An updated systematic review of neuroprotective agents in the treatment of spinal cord injury

Spinal Cord Injury: Emerging Technologies

Traumatic Spinal Cord Injury

Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications

Spinal cord injury: molecular mechanisms and therapeutic interventions

Advancements in neuroregenerative and neuroprotective therapies for traumatic spinal cord injury

Spinal cord injury (SCI)—Prehospital management